Amwell Hopes To Raise $560M In IPO, Google Invests $100M

11 Sep 2020

Telehealth company Amwell priced its stock between $14 and $16 per share for its planned IPO and partnered with Google for its cloud services.

IPO Initial Private Offering Stock Market Ticker Building 3d Illustration

Telehealth company Amwell hopes to raise $560m in an initial public offering, according to an S-1 registration statement. The company said it will offer 35 million shares of its class A common stock priced between $14 and $16 a share.

Morgan Stanley, Goldman Sachs & Co. LLC and Piper Sandler will act as the joint bookrunning managers for the proposed offering.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Guardant Health Launches Germline Hereditary Cancer Test

22 May 2025

• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.

Bringing Israeli Medical Device Candidates To The Right Partners In The US

19 May 2025

• By Ashley Yeo

Despite regional unrest, it is business as usual for medtech innovators and investors in Israel as evidenced by continued high-value M&A of locally developed technologies. Irit Yaniv, co-chair of the medtech session at the upcoming BioMed Israel 2025, explained the unique dynamics of Israeli medtech innovation.

SpotitEarly Raised $20.3M In New Funding To Bring AI- And Dog-Sniffing-Powered Early Cancer Detection Test To US

16 May 2025

• By Marion Webb

Israeli-based SpotitEarly hopes to bring an early cancer-detection test, which uses dogs’ noses to detect compounds in exhaled breath and AI analysis, to US homes in 2026.

Consumer Healthtech Investment Totaled $4.5BN In 2024, But Bar Is High Amid Economic Uncertainty

07 May 2025

• By Marion Webb

Global investment in consumer healthtech increased by 9% year-over-year in 2024, totaling $4.5bn, with significant interest in mental health solutions, according to Galen Growth. While the first quarter of 2025 saw raised confidence and investments, the Trump administration’s new tariffs and sweeping changes to healthcare have introduced new uncertainties.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

20 May 2025

• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.